Anthony Maddaluna - Pfizer Insider

PFE -- Germany Stock  

EUR 32.28  0.39  1.22%

Executive Vice President and Presidentident - Pfizer Global Supply
Mr. Anthony J. Maddaluna is Executive Vice President President Pfizer Global Supply of the Company. He was President Pfizer Global Supply from 2011 until December 2012. Senior Vice President Strategy Supply Network Transformation from 2009 until December 2010. Vice President Strategy Supply Network Transformation from 2008 until 2009. Vice President and Team Leader Europe from 1998 until 2008 including responsibility for global logistics and strategic planning from 2005 through 2008
Age: 62  President Since 2013      
212-733-2323  http://www.pfizer.com
Maddaluna represents Pfizer on the National Association of Manufacturers and is a member of the NAM Executive Committee. Director of Albany Molecular Research Inc.

Anthony Maddaluna Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 5.66 % which means that it generated profit of $5.66 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 33.71 % meaning that it generated $33.71 on every $100 dollars invested by stockholders.
The company has accumulated 41.27 B in total debt with debt to equity ratio (D/E) of 58.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer has Current Ratio of 1.24 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug Manufacturers - Major classification in Germany and traded on Frankfurt Stock Exchange. It employs 90200 people.Pfizer (PFE) is traded on Frankfurt Stock Exchange in Germany. It is located in 235 East 42nd Street and employs 90,200 people.

Pfizer Leadership Team

John Young, President
Frank DAmelio, President
Douglas Lankler, President
Helen Hobbs, Director
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Wyllie Cornwell, Director
Suzanne Johnson, Director
Alexander Mackenzie, President
Geno Germano, President
Laurie Olson, President
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
Dan Littman, Director, Ph.D
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President, Ph.D
Kirsten LundJurgensen, President
Angela Hwang, President
Ronald Blaylock, Director
Kathrin Jansen, President, Ph.D

Stock Performance Indicators

Current Sentiment - PFE

Pfizer Investor Sentiment
Most of Macroaxis users are at this time bullish on Pfizer. What is your perspective on investing in Pfizer? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
BND   
Purchased few shares of
few hours ago
Traded for 79.19
QQQ   
Purchased few shares of
few hours ago
Traded for 179.93
SPY   
Purchased few shares of
few hours ago
Traded for 281.04
TRP   
Sold one share of
few hours ago
Traded for 42.84
KO   
Purchased over 90 shares of
few hours ago
Traded for 45.12
Additionally take a look at Your Equity Center. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.